美股异动 | 脑再生科技涨超 18% 总市值超 48 亿美元
On Wednesday, Regencell Bioscience's stock price soared, rising over 18% as of the time of publication, reaching USD 370.43, with a market capitalization exceeding USD 4.8 billion. Regencell Bioscience is an early-stage biotech company focused on traditional Chinese medicine treatments for neurocognitive disorders and degenerative diseases. The company was established on October 30, 2014, and is registered in the Cayman Islands, primarily operating through its subsidiary in Hong Kong
According to Zhitong Finance APP, on Wednesday, Regencell Bioscience (RGC.US) stock price soared, rising over 18% as of the time of publication, trading at $370.43, with a market capitalization exceeding $4.8 billion. Regencell Bioscience is an early-stage biotechnology company focused on traditional Chinese medicine treatments for neurocognitive disorders and degenerative diseases. The company was established on October 30, 2014, and is registered in the Cayman Islands, primarily operating through its subsidiary in Hong Kong
